Dan Aravot

VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel.

Lartim Medical Ltd. operates as a development stage company. The company was founded by Boris Orlov in 2008 and is headquartered in Kiryat Shmona, Israel.

OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel.

New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY.

CMT Medical Technologies Ltd. designs, develops, manufactures and markets digital image processing systems for use in medical diagnostic imaging applications. CMT is also engaged in the development of X-ray detectors for various medical applications. The Group offers two types of products for digital X-ray imaging needs: SmartRAD - General Radiography Digital Imaging and SmartSPOT PrimaX. The SmartSPOT PrimaX provides solutions for R&F rooms and angiography suites. SmartSPOT systems enable hospitals to leverage their investment in existing equipment by prolonging equipment life, accelerating procedures, saving film and reducing patients' exposure to radiation. The company was founded in 1981 and is headquartered in Yokneam Elit, Israel.